To be presented at the San Antonio Meeting:
9:30-11:15 GENER AL SESSION 5– Exhibit Hall D
9:30
61. Updated Survival Analysis of a Randomized Study of Lapatinib Alone or
in Combination with Trastuzumab in Women with HER 2-Positive Metastatic
Breast Cancer Progressing on Trastuzumab Therapy
Blackwell KL, Burstein HJ, Sledge GW, Stein S, Ellis C, Casey M, Baselga J,
O’Shaughnessy J. Duke University Medical Center, Durham, NC; Dana-Farber
Cancer Institute, Boston, MA; Indiana University Cancer Center, Indianapolis, IN;
GlaxoSmithKline, Collegeville, PA; Vall d’Hebron University Hospital, Barcelona,
Spain; Baylor Sammons Cancer Center, Texas Oncology, PA, US Oncology, Dallas, TX